Paper Details
- Home
- Paper Details
Effects of inhaled corticosteroids on bone.
Author: BootsmaG P, DekhuijzenP N, FestenJ, van HerwaardenC L
Original Abstract of the Article :
Inhaled corticosteroids (ICS) are the most effective therapy for asthma currently available. The increasing use of ICS raises the issue of possible adverse systemic effects. Since one of the most important side-effects of oral corticosteroids (OCS) is osteoporosis, this article focuses on current kn...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0300-2977(97)00028-4
データ提供:米国国立医学図書館(NLM)
Inhaled Corticosteroids: Navigating the Complex Landscape of Bone Health
Inhaled corticosteroids (ICS), like a refreshing oasis in the desert, have revolutionized the treatment of asthma. However, like any powerful remedy, ICS use may come with potential side effects. This study investigates the effects of ICS on bone health, focusing on the potential for bone loss and the clinical implications of these findings.
The Bone Connection: Understanding ICS's Impact on Bone Health
The study acknowledges the dose-dependent decrease in serum osteocalcin levels associated with high doses of ICS. While some studies have suggested potential decreases in bone density with ICS use, the researchers emphasize the difficulty in isolating the specific contribution of ICS from other confounding factors. The clinical relevance of these observations in the long term remains unclear, and further research is needed to definitively assess the impact of ICS on fracture risk.
A Balancing Act: Optimizing Asthma Treatment While Protecting Bone Health
This research underscores the importance of a balanced approach to asthma treatment, prioritizing the use of the lowest effective dose of ICS to minimize potential side effects. Clinicians should carefully monitor bone health in patients receiving ICS therapy, particularly those at increased risk for osteoporosis. The study highlights the need for continued research to better understand the long-term impact of ICS on bone health.
Dr. Camel's Conclusion
This study, like a camel caravan cautiously navigating a desert landscape, explores the complex relationship between inhaled corticosteroids and bone health. While ICS offer a valuable tool for asthma management, the research highlights the importance of careful consideration of potential side effects. By prioritizing the lowest effective dose and monitoring bone health, clinicians can effectively manage asthma while mitigating potential risks to bone health, ensuring a balanced and safe approach to patient care.
Date :
- Date Completed 1997-08-19
- Date Revised 2019-11-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.